Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Innovaderma Plc LSE:IDP London Ordinary Share GB00BT9PTW34 ORD EUR0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 1.22% 41.50 40.00 43.00 42.50 41.00 42.00 69,261 09:13:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 10.1 1.1 5.5 8.2 7

John McWall Form 8.3 - InnovaDerma PLC

23/02/2021 1:51pm

UK Regulatory (RNS & others)


Innovaderma (LSE:IDP)
Historical Stock Chart


From Feb 2021 to Mar 2021

Click Here for more Innovaderma Charts.

TIDMIDP

RNS Number : 0726Q

John McWall

23 February 2021

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the " Code " )

   1.         KEY INFORMATION 
 
      (a) Full name of discloser:              John McWall 
      (b) Owner or controller of interests     Not Applicable 
       and short positions disclosed, 
       if different from 1(a): 
       The naming of nominee or vehicle 
       companies is insufficient. For 
       a trust, the trustee(s), settlor 
       and beneficiaries must be named. 
                                              ------------------------ 
      (c) Name of offeror/offeree in           InnovaDerma PLC 
       relation to whose relevant securities 
       this form relates: 
       Use a separate form for each 
       offeror/offeree 
                                              ------------------------ 
      (d) If an exempt fund manager            Not Applicable 
       connected with an offeror/offeree, 
       state this and specify identity 
       of offeror/offeree: 
                                              ------------------------ 
      (e) Date position held/dealing           19 February 2021 
       undertaken: 
       For an opening position disclosure, 
       state the latest practicable date 
       prior to the disclosure 
                                              ------------------------ 
      (f) In addition to the company           YES / NO / N/A 
       in 1(c) above, is the discloser          If YES, specify which: 
       making disclosures in respect            No 
       of any other party to the offer? 
       If it is a cash offer or possible 
       cash offer, state "N/A" 
                                              ------------------------ 
 
   2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
 Class of relevant security:                        0.10EUR ORDINARY 
                                             Interests       Short positions 
                                          ---------------  ------------------ 
                                           Number     %        Number      % 
                                          --------         -------------  --- 
      (1) Relevant securities 
       owned and/or controlled:            230,000   1.32 
                                          --------  -----  -------------  --- 
      (2) Cash-settled derivatives:         6,000    0.03 
                                          --------  -----  -------------  --- 
      (3) Stock-settled derivatives 
       (including options) 
       and agreements to purchase/sell: 
                                          --------  -----  -------------  --- 
 
   TOTAL:                                  236,000   1.35 
                                          --------  -----  -------------  --- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

 
 Class of relevant security 
  in relation to which subscription 
  right exists: 
 Details, including nature 
  of the rights concerned and 
  relevant percentages: 
 
 
   3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)        Purchases and sales 
 
 Class of relevant   Purchase/sale   Number of securities   Price per unit 
      security 
 
 
   (b)        Cash-settled derivative transactions 
 
 Class of      Product         Nature of dealing       Number of    Price per 
  relevant    description     e.g. opening/closing     reference       unit 
  security     e.g. CFD      a long/short position,    securities 
                              increasing/reducing 
                             a long/short position 
 
 
   (c)        Stock-settled derivative transactions (including options) 
   (i)         Writing, selling, purchasing or varying 
 
    Class         Product        Writing,         Number       Exercise         Type         Expiry    Option 
  of relevant    description    purchasing,    of securities     price      e.g. American,    date      money 
   security       e.g. call      selling,        to which       per unit       European                 paid/ 
                   option         varying         option                         etc.                  received 
                                   etc.           relates                                              per unit 
 
 
   (ii)        Exercise 
 
 Class of relevant   Product description   Exercising/    Number of    Exercise price 
      security            e.g. call         exercised     securities      per unit 
                            option           against 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant    Nature of dealing    Details         Price per 
      security        e.g. subscription,              unit (if applicable) 
                          conversion 
 
 
   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any 
  agreement or understanding, formal or informal, relating 
  to relevant securities which may be an inducement to deal 
  or refrain from dealing entered into by the person making 
  the disclosure and any party to the offer or any person 
  acting in concert with a party to the offer: 
  Irrevocable commitments and letters of intent should not 
  be included. If there are no such agreements, arrangements 
  or understandings, state "none" 
 NONE 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, 
  formal or informal, between the person making the disclosure 
  and any other person relating to: 
  (i) the voting rights of any relevant securities under 
  any option; or 
  (ii) the voting rights or future acquisition or disposal 
  of any relevant securities to which any derivative is 
  referenced: 
  If there are no such agreements, arrangements or understandings, 
  state "none" 
  NONE 
 
   (c)        Attachments 
 
 Is a Supplemental Form 8 (Open Positions) attached? 
  N0 
 
 
 Date of disclosure:   22 February 2021 
 Contact name:         John McWall 
                      ----------------- 
 Telephone number*: 
                      ----------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETDZGZZZFFGMZM

(END) Dow Jones Newswires

February 23, 2021 08:51 ET (13:51 GMT)

1 Year Innovaderma Chart

1 Year Innovaderma Chart

1 Month Innovaderma Chart

1 Month Innovaderma Chart
ADVFN Advertorial
Your Recent History
LSE
IDP
Innovaderm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210307 10:13:26